Mary E Haas Selected Research

O(4)-methylthymidine triphosphate

1/2022

A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary E Haas Research Topics

Disease

4	Liver Diseases (Liver Disease) 01/2022 - 01/2020
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 06/2012
3	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2021
2	Atherosclerosis 12/2022 - 08/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2015
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 10/2018
2	Obesity 01/2019 - 06/2012
2	Hypercholesterolemia 07/2016 - 04/2016
1	Kidney Diseases (Kidney Disease) 12/2022
1	Atherosclerotic Plaque (Atheroma) 12/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Insulin Resistance 11/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021
1	Fatty Liver 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Genetic Risk Score 01/2019
1	Albuminuria 10/2018
1	Neoplasms (Cancer) 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2016
1	Lipodystrophy 04/2016
1	Body Weight (Weight, Body) 04/2016
1	Inflammation (Inflammations) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2015
1	Dyslipidemias (Dyslipidemia) 06/2012

Drug/Important Bio-Agent (IBA)

5	CholesterolIBA 12/2022 - 07/2015
4	Insulin (Novolin)FDA Link 01/2016 - 06/2012
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
3	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2020
3	LipidsIBA 11/2021 - 04/2016
3	Proprotein Convertase 9IBA 07/2016 - 07/2015
2	Apolipoproteins B (ApoB)IBA 01/2022 - 08/2013
2	Lipoproteins (Lipoprotein)IBA 11/2021 - 08/2013
2	amidoximeIBA 04/2021 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 06/2012
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019 - 04/2016
2	oxidized low density lipoproteinIBA 01/2019 - 04/2016
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2022
1	SubtilisinIBA 12/2022
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 12/2022
1	Urokinase Plasminogen Activator ReceptorsIBA 12/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	O(4)-methylthymidine triphosphateIBA 01/2022
1	Activins (Activin)IBA 01/2022
1	Inhibins (Inhibin)IBA 01/2022
1	Oleic Acid (Oleate)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	Apolipoproteins E (ApoE)IBA 11/2021
1	acetoacetic acid (acetoacetate)IBA 11/2021
1	EnzymesIBA 01/2020
1	Alkaline PhosphataseIBA 01/2020
1	LDL CholesterolIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	HDL CholesterolIBA 01/2019
1	HDL LipoproteinsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	AlbuminsIBA 10/2018
1	P-2 (P 2)IBA 10/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Caspase 8 (Caspase-8)IBA 07/2016
1	PCSK9 InhibitorsIBA 07/2016
1	A 7 (A-7)IBA 07/2016
1	LeptinIBA 04/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016
1	Liver X ReceptorsIBA 01/2016
1	LDL Receptors (LDL Receptor)IBA 07/2015
1	ApolipoproteinsIBA 08/2013
1	Sterol Regulatory Element Binding Protein 1IBA 06/2012
1	Messenger RNA (mRNA)IBA 06/2012
1	Insulin ReceptorIBA 06/2012
1	Antisense OligonucleotidesIBA 06/2012

Therapy/Procedure

1	Bariatric Surgery 01/2022
1	Replacement Arthroplasty 01/2019